Mars Inc. will combine its chocolate operations with its Wrigley subsidiary, as it buys the minority stake in the chewing gum unit from Warren Buffett’s Berkshire Hathaway.
Mars said it accelerated its plan to purchase Berkshire’s Wrigley holding but didn’t disclose financial details. A spokesman for Wrigley didn’t immediately reply to a request for comment.
The move to combine its chocolate business with Wrigley will put brands such as Snickers candy bars and Doublemint gum into one operating segment. Other divisions at Mars, such as petcare and beverages, will remain separate.
The two units will form an entity called Mars Wrigley Confectionery and be led by Martin Radvan, current president of Wrigley and a 30-year veteran of Mars.
Wall Street was surprised by the $23 billion deal that privately held Mars, backed by Berkshire, struck to buy then-publicly-traded Wrigley in 2008.
Berkshire contributed about $6.5 billion to the deal, including $2.1 billion for dividend-paying preferred stock in Wrigley and $4.4 billion in bonds. Mars bought back the bonds in 2013, netting Berkshire a pretax investment gain of $680 million.
Mars had become eligible to purchase half of Berkshire’s Wrigley stake on Thursday, and Berkshire said in a recent filing that it had expected those shares to be purchased. Now, however, Mars will instead purchase the full stake held by Berkshire.
The original Wrigley deal was one of several lucrative investments Mr. Buffett struck during the financial crisis, using Berkshire’s cash-rich position to lend money at high interest rates at a time when credit markets were tight.
On Thursday, Mr. Buffett said “I have enjoyed all of Berkshire’s experiences with the Mars family and management and wish them the very best. Both Mars and Berkshire have profited from our investment, and that’s the way it should be.”
Mars chocolate and Wrigley are set to combine sometime next year. Mars Wrigley Confectionery will be based out of Chicago. Mars Inc. is based in McLean, Va.
By Joshua Jamerson
Source: Wall Street Journal
Free-from is becoming much more mainstream, moving beyond food allergens and intolerances. While it’s still vital to innovate products for lactose intolerance, gluten allergies and so forth, the umbrella term of free-from has taken on many different meanings.
Arla Foods Ingredients (AFI) is targeting infant formula, sports nutrition and medical nutrition with its new patented milk fractionation technology that separates milk proteins from whey, bypassing the need to make cheese. The Denmark-based company says this move enables scientists, nutritionists and health professionals to create “next-generation” dairy products.
Located in Ma’anshan, Anhui province, the facility has the potential to produce an estimated 150 million litres of oat-based products annually at full capacity. The opening comes just a few months after Oatly – which claims to have established a new Chinese character for ‘plant-based milk’ – inaugurated its first Asian factory in Singapore.